Deep sequence models for blood glucose forecasting consistently fail to leverage clinically informative drivers--insulin, meals, and activity--despite well-understood physiological mechanisms. We term this Driver-Blindness and formalize it via $Δ_{\text{drivers}}$, the performance gain of multivariate models over matched univariate baselines. Across the literature, $Δ_{\text{drivers}}$ is typically near zero. We attribute this to three interacting factors: architectural biases favoring autocorrelation (C1), data fidelity gaps that render drivers noisy and confounded (C2), and physiological heterogeneity that undermines population-level models (C3). We synthesize strategies that partially mitigate Driver-Blindness--including physiological feature encoders, causal regularization, and personalization--and recommend that future work routinely report $Δ_{\text{drivers}}$ to prevent driver-blind models from being considered state-of-the-art.